All News Archive — Page 5 of 168

August 18, 2026

Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling

The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.

August 18, 2026

Vanderbilt Health’s Annet Kirabo to receive major award for hypertension research 

The award will be presented Oct. 10 during the American Heart Association’s Hypertension Scientific Session in Arlington, Virginia.

August 14, 2026

Discover what’s next in cancer at Aug. 22 symposium

The symposium is free and open to people affected by neurofibromatosis and schwannomatosis, as well as their families, loved ones and caregivers.

August 14, 2026

EHR-embedded tool extracts liver stiffness values to prevent gaps in care

Vanderbilt Health researchers developed a natural language processing tool that can efficiently identify patients with liver disease and streamline assessment for treatments.

August 13, 2026

Yale’s Jasmiry Bennett named Vice President and Chief Advanced Practice Officer for Vanderbilt Health

As Vanderbilt Health’s first Vice President and Chief Advanced Practice Officer, Bennett will provide strategic leadership for the APP community across the enterprise and help shape the future of advanced practice.

Alaina Davis, MD
August 12, 2026

Alaina Davis named inaugural recipient of Ripple Effect Award for juvenile arthritis advocacy

The new honor recognizes an individual whose compassion, leadership and dedication have made a lasting impact on the juvenile arthritis community.